Literature DB >> 22159481

[Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia].

Carmelo José Espinosa1, Jorge Alberto Cortés, Juan Sebastián Castillo, Aura Lucía Leal.   

Abstract

INTRODUCTION: Bacterial resistance is a public health problem worldwide whose proper management requires knowledge of its presence and its behavior in each region and country.
OBJECTIVES: A survey of the medical literature was conducted to identify levels of resistance to antibiotic markers in Gram positive bacterial isolates from Colombian hospitals.
MATERIALS AND METHODS: A systematic review of the literature included articles indexed in MEDLINE and LILACS. A manual search was made of Colombian scientific journals and other infectious disease literature not available electronically.
RESULTS: A total of 34 observational studies were located, including a series of consecutive reports initiated in 2001. Most of the reports came from the city of Bogota. The rate of methicillin resistance for Staphylococcus aureus and coagulase-negative staphylococci in non intensive care unit isolates ranged between 35%-50% and 72%-76%, respectively. Resistance in intensive care unit isolates had a range between 35%-71% and 74%-83%, respectively. The rate of vancomycin-resistant Enterococcus faecium averaged less than 20% over the years but with large annual variation .
CONCLUSIONS: Resistance markers appeared in high frequency among Gram positive isolates identified in hospitals in major Colombian cities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159481     DOI: 10.1590/S0120-41572011000100005

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  1 in total

1.  Using Positive Deviance in the prevention and control of MRSA infections in a Colombian hospital: a time-series analysis.

Authors:  N M Olarte Escobar; I A Valderrama Márquez; J Avila Quiroga; T Goretty Trujillo; F González; M I Garzón Aguilar; J Escobar-Pérez
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.